Fortress Biotech competitors

Fortress Biotech Competitors include Origene Technologies, Kezar Life Sciences, Lonza and Aptuit.
Add company...
Fortress Biotech
Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.
Origene Technologies
OriGene Technologies, a research tool company, provides a commercial collection of full-length human cDNAs.
Kezar Life Sciences
Kezar Life Sciences is focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders.
Lonza
Lonza supplies active ingredients, chemical intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries.
Aptuit
Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions.
Founding Date
Founding Date
2006
Founding Date
1996
Founding Date
2015
Founding Date
1897
Founding Date
1993
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
New York, US HQ
Locations
Rockville, US HQ
Beijing, CN
Herford, DE
Locations
South San Francisco, US HQ
Locations
Basel, CH HQ
Mt Waverley, AU
Verviers, BE
São Paulo, BR
Suzhou, CN
San José, CR
Kouřim, CZ
see more
Locations
Greenwich, US HQ
Verona, IT
Reinach, CH
Milton, GB
Employees
Employees
45
Employees
971% decrease
Employees
N/A
Employees
14,618
Employees
N/A
Valuation ($)
Valuation ($)
72.3 m
Valuation ($)
N/A
Valuation ($)
418.5 m
Valuation ($)
16.4 b
Valuation ($)
N/A
Facebook likes
Facebook likes
22
Facebook likes
12.2 k
Facebook likes
N/A
Facebook likes
31.4 k
Facebook likes
N/A
Twitter followers
Twitter followers
312
Twitter followers
606
Twitter followers
N/A
Twitter followers
4.9 k
Twitter followers
722

Financial

Revenue (est.)
Revenue (est.)
$16.5m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
CHF5.1b (FY, 2017)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$790k (FY, 2016)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
CHF3.3b (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
$15.7m (FY, 2016)
Gross profit
N/A
Gross profit
N/A
Gross profit
CHF1.8b (FY, 2017)
Gross profit
N/A
Net income
Net income
($71.3m) (FY, 2016)
Net income
N/A
Net income
N/A
Net income
CHF728m (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 69.6m
Total funding raised
$ 78.3m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Origene Technologies
HQ
Rockville, US
Employees
97↓ 1% decrease

OriGene Technologies, a research tool company, provides a commercial collection of full-length human cDNAs.

View company
Kezar Life Sciences
HQ
South San Francisco, US

Kezar Life Sciences is focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders.

View company
Lonza
HQ
Basel, CH
Employees
14,618

Lonza supplies active ingredients, chemical intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries.

View company
Aptuit
HQ
Greenwich, US

Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions.

View company